Enzyme inhibitor and chemotherapy combination regresses glioblastoma

[News]

In animal experiments, a human-derived glioblastoma significantly regressed when treated with the combination of an experimental enzyme inhibitor and the standard glioblastoma chemotherapy drug, temozolomide.

More... (https://www.news-medical.net/news/20180124/Enzyme-inhibitor-and-chemotherapy-combination-regresses-glioblastoma.aspx)